Vitamin B12 (Cobalamin)

What Is It?

Functions (Two Key Enzymatic Reactions)

1. Methionine Synthesis (Methylcobalamin pathway)

• Methylcobalamin transfers a methyl group from N5-methyltetrahydrofolate (N5-MTHF) to homocysteine, converting it to methionine
• Without B12, folate becomes "trapped" as N5-MTHF and cannot be converted to active tetrahydrofolate (THF)
• This leads to failure of DNA synthesis (specifically depletion of dTMP and purines) in rapidly dividing cells

2. Methylmalonyl-CoA Mutase (Deoxyadenosylcobalamin pathway)

• Converts methylmalonyl-CoA to succinyl-CoA
• Methylmalonyl-CoA accumulates in deficiency, causing urinary excretion of methylmalonic acid (MMA) - an important diagnostic marker
• Harper's Illustrated Biochemistry, 32nd Ed

Absorption - The Intrinsic Factor Pathway

1. B12 is released from food in the stomach/duodenum
2. It binds to intrinsic factor (IF), a glycoprotein secreted by gastric parietal cells
3. The B12-IF complex is absorbed in the distal ileum via a receptor-mediated transport system
4. Once absorbed, it is carried in blood bound to transcobalamin I, II, and III
5. Excess is stored in the liver (total body store: 3,000-5,000 mcg)

Deficiency

Causes

• Most common: Lack of intrinsic factor (pernicious anemia) due to autoimmune destruction of parietal cells or anti-IF antibodies
• Ileal resection or Crohn's disease (loss of absorption site)
• Strict veganism (inadequate dietary intake over years)
• Gastric surgery (total gastrectomy)
• Tapeworm infection (Diphyllobothrium latum competes for B12)
• Bacterial overgrowth (bacteria bind the B12-IF complex)

Effects

"Demyelination of nerve fibers in people with vitamin B12 deficiency occurs especially in the posterior columns, and occasionally the lateral columns, of the spinal cord." - Guyton & Hall Textbook of Medical Physiology

The "Folate Trap"

Diagnosis

• Serum B12 - most common initial test (low in deficiency)
• Serum methylmalonic acid (MMA) - elevated; highly specific for B12 deficiency
• Plasma homocysteine - elevated (also raised in folate and B6 deficiency)
• Holotranscobalamin - the active fraction of B12; sensitive early marker
• Blood film: macrocytes, hypersegmented neutrophils
• Anti-intrinsic factor antibodies: confirm pernicious anemia

Treatment

• Intramuscular hydroxocobalamin or cyanocobalamin - preferred when absorption is impaired (e.g., pernicious anemia)
• High-dose oral B12 (1,000 mcg/day) - effective even without intrinsic factor because ~1% of oral B12 is absorbed passively by diffusion
• Lifelong treatment is required in pernicious anemia and other permanent malabsorption conditions

At-Risk Groups

• Strict vegans and vegetarians
• Elderly (decreased gastric acid and IF production)
• Patients on long-term metformin (reduces B12 absorption)
• Patients on long-term proton pump inhibitors
• Those with inflammatory bowel disease or prior gastric surgery

How Alcohol Causes Thiamine (Vitamin B1) Deficiency

1. Inadequate Dietary Intake (Most Important Mechanism)

• Replace calorie-dense nutritious food with alcohol (alcohol itself provides ~7 kcal/g but carries almost no micronutrients)
• Have poor appetite, neglect regular meals, and may have financial difficulties limiting food access
• As a result, total thiamine intake from diet falls far below the daily requirement (~1.2 mg/day)

2. Impaired Intestinal Absorption

• Alcohol inhibits thiamine transporter-1 (THTR-1) in the jejunal brush-border membrane, blocking active uptake of thiamine into enterocytes
• Alcohol also impairs the movement of thiamine from within the enterocyte through the basolateral membrane into portal circulation
• Folate deficiency (which alcohol also causes) further reduces thiamine absorption from the GI tract
• Direct damage to the intestinal mucosa by alcohol also contributes to impaired absorption
• At low, physiological thiamine concentrations (the normal range), transport is almost entirely via this active, energy-dependent transporter - so inhibiting it has a large effect
• Kaplan & Sadock's Comprehensive Textbook of Psychiatry

3. Impaired Hepatic Storage and Phosphorylation

• Alcohol-related liver disease (fatty liver, hepatitis, cirrhosis) impairs the liver's ability to store thiamine and convert it to TPP
• Reduced TPP means reduced activity of the three enzymes that depend on it (see below)
• The liver normally holds a significant thiamine reserve; this reserve is depleted in chronic alcoholism

4. Increased Urinary Excretion

• Alcohol has a mild diuretic effect, increasing urine output
• This leads to increased renal loss of water-soluble vitamins including thiamine
• The body cannot compensate if intake and absorption are already compromised

5. Increased Metabolic Demand

• High carbohydrate intake from alcohol itself (and from food if eating) increases the demand for thiamine, because TPP is a cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase - both enzymes in glucose metabolism
• This means the body's thiamine stores are consumed faster, worsening deficiency

What Thiamine (TPP) Does: The Biochemical Impact of Deficiency

The Neurological Consequences

Wernicke Encephalopathy (Acute)

1. Confusion / altered mental status
2. Ophthalmoplegia (eye movement abnormalities, nystagmus)
3. Ataxia (cerebellar gait disturbance)

Korsakoff Syndrome (Chronic - largely irreversible)

• Anterograde amnesia (inability to form new memories)
• Retrograde amnesia
• Confabulation (fabricating memories without awareness)
• Develops when Wernicke encephalopathy is untreated or undertreated

"Beyond malnutrition, alcohol use induces thiamine deficiency through folate deficiency (which reduces thiamine absorption from the GI tract) and through direct damage to the intestinal mucosa." - Kaplan & Sadock's Comprehensive Textbook of Psychiatry

Molecular Mechanisms of Neuronal Damage in Thiamine Deficiency

• Cerebral energy failure (ATP depletion due to impaired glucose oxidation)
• Glutamate excitotoxicity - via NMDA receptors
• Blood-brain barrier breakdown
• Oxidative stress (free radical production, increased superoxide dismutase)
• Nitric oxide induction
• Neurotransmitter disruption - acetylcholine, GABA, glutamate, serotonin are all affected (TPP is needed for neurotransmitter synthesis via glucose metabolism)

Summary Diagram

Chronic Alcohol Use
       |
       ├── Poor diet → ↓ Thiamine intake
       ├── Inhibits THTR-1 → ↓ GI absorption
       ├── Folate deficiency → further ↓ absorption
       ├── Liver damage → ↓ storage & phosphorylation
       ├── Diuresis → ↑ urinary excretion
       └── ↑ Carbohydrate load → ↑ Thiamine demand
                        |
                   ↓ Thiamine (TPP)
                        |
          ┌─────────────┼──────────────┐
     ↓ PDH          ↓ α-KGDH      ↓ Transketolase
          |
     Brain energy failure
          |
   Wernicke Encephalopathy → (if untreated) → Korsakoff Syndrome

Treatment Note

Methylcobalamin in Neuropathic Pain

What Is Methylcobalamin?

Mechanisms of Analgesic Action in Neuropathic Pain

1. Improves Nerve Conduction Velocity

• High-dose MeCbl promotes synthesis and regeneration of myelin
• Morphological and histological recovery of myelin improves nerve conduction velocity and neuronal function in peripheral neuropathy
• Demonstrated in diabetic neuropathy patients, streptozotocin-diabetic rat models, and experimental acrylamide neuropathy

2. Promotes Regeneration of Injured Nerves

• MeCbl activates the methylation cycle, which activates ERK1/2 and Akt signaling pathways that drive nerve repair
• Increases protein synthesis in crushed/injured nerve tissue (measured by leucine incorporation into sciatic nerve)
• Significantly increases the number of regenerating motor nerve fibers
• Combined use with L-methylfolate and pyridoxal-5-phosphate (active B6) improves neural density in muscle tissue

3. Inhibits Ectopic Spontaneous Discharges

• In neuropathic pain, damaged primary sensory neurons fire abnormal, spontaneous electrical discharges that drive ongoing pain
• MeCbl suppresses these ectopic discharges from injured dorsal root ganglion (DRG) neurons
• This reduces peripheral sensitization - the main driver of allodynia and hyperalgesia in neuropathic pain

Additional Mechanism:

• MeCbl antagonizes glutamate-induced neurotoxicity (excitotoxicity), which is an important contributor to nerve damage and central sensitization in chronic pain

Clinical Evidence

Systematic Review & Meta-Analysis (2020) - PMID: 32716261

• 15 RCTs, 1,707 patients with diabetic peripheral neuropathy and herpetic neuropathy
• MeCbl combination therapy was more effective than active control for clinical therapeutic efficacy (RR = 1.32; 95% CI 1.21-1.45)
• Improved nerve conduction velocities (NCV) significantly with combination therapy
• MeCbl alone showed modest benefit (RR = 1.17) but did not reach significance on pain score alone
• No serious adverse events reported
• Conclusion: MeCbl in combination is effective; monotherapy evidence is less clear

Triple Combination Therapy Meta-Analysis (2024) - PMID: 38330524

• 9 RCTs, 1,153 patients with diabetic peripheral neuropathy
• Alpha-lipoic acid + Epalrestat + Mecobalamin (triple combination) was significantly superior to mono or dual therapy
• OR = 3.74 (95% CI 2.57-5.45) for therapeutic outcomes
• Significant improvements in motor and sensory nerve conduction velocities and vibration perception thresholds

Conditions Where MeCbl Is Used for Neuropathic Pain

Practical Dosing

• Significant demyelination is present
• GI absorption is impaired
• Diabetic neuropathy is established

Important Caveats

1. B12 deficiency vs. normal B12: MeCbl is clearly effective when neuropathy is driven by B12 deficiency. In neuropathic pain patients with normal B12 levels, MeCbl's analgesic benefit exists but is smaller - it acts through its nerve-regenerative effects rather than correcting deficiency
2. It is NOT a first-line analgesic alone - it should be used alongside evidence-based neuropathic pain agents (pregabalin, duloxetine, amitriptyline) as an adjunct or disease-modifying agent
3. Safety: Very well tolerated - no serious adverse events in trials, even at high doses. It is water-soluble so toxicity is not a concern at therapeutic doses
4. Metformin users: Diabetic patients on metformin have reduced B12 absorption - checking B12 and supplementing with MeCbl is especially important in this group